# EDGAR Filing Document

**Accession Number:** 0001684144
**File Stem:** 0001654954-25-009862
**Filing Date:** 2025-8
**Character Count:** 4738
**Document Hash:** d92ee3f288c5c0cf67a98eb3bec71f0a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001654954-25-009862.hdr.sgml**: 20250820

**ACCESSION NUMBER**: 0001654954-25-009862

**CONFORMED SUBMISSION TYPE**: 8-A12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250820

**DATE AS OF CHANGE**: 20250820

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Zomedica Corp.
- **CENTRAL INDEX KEY:** 0001684144
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-A12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56775
- **FILM NUMBER:** 251236944

**BUSINESS ADDRESS:**
- **STREET 1:** 100 PHOENIX DRIVE
- **STREET 2:** SUITE 125
- **CITY:** ANN ARBOR
- **STATE:** MI
- **ZIP:** 48108
- **BUSINESS PHONE:** (734) 369-2555

**MAIL ADDRESS:**
- **STREET 1:** 100 PHOENIX DRIVE
- **STREET 2:** SUITE 125
- **CITY:** ANN ARBOR
- **STATE:** MI
- **ZIP:** 48108

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Zomedica Pharmaceuticals Corp.
- **DATE OF NAME CHANGE:** 20160908

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-A**

**FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES**

**PURSUANT TO SECTION 12(b) OR 12(g) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

---

| |
|:---|
| **ZOMEDICA CORP.** |
| **(Exact name of registrant as specified in its charter)** |

---

---

| | |
|:---|:---|
| **Alberta, Canada** | **N/A** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification Number) |

---

**1101 Technology Drive, Suite 100**

**Ann Arbor, Michigan 48108**

**(Address of principal executive offices, including zip code)**

Securities to be registered pursuant to Section 12(b) of the Act:

---

| | |
|:---|:---|
| **Title of each class** <br> **to be so registered** | **Name of each exchange on which** <br> **each class is to be registered** |
| None. | N/A |

---

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☐

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☒

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

Securities Act registration statement or Regulation A offering statement file number to which this form relates:

Securities to be registered pursuant to Section 12(g) of the Act: **Common Shares, without par value**

**Item 1. Description of Registrant's Securities to be Registered.**

The description of the securities being registered is set forth under "Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934" in Exhibit 4.1 to the Registrant's Annual Report on Form 10-K for the year ended December 31, 2019 (File No. 001-38298), originally filed with the Securities and Exchange Commission on February 26, 2020, which description is incorporated herein by this reference.

**Item 2. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| [3.1](http://www.sec.gov/Archives/edgar/data/1684144/000117184321003435/exh_31.htm) | [Articles of Amalgamation of Zomedica Corp. and all amendments thereto, as well as all Certificates issued in respect thereto (incorporated by reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q filed with the Commission on May 12, 2021 (File No. 001-38298))](http://www.sec.gov/Archives/edgar/data/1684144/000117184321003435/exh_31.htm) |
| [3.2](http://www.sec.gov/Archives/edgar/data/1684144/000117184320005754/exh_31.htm) | [Amended and Restated By-Law No. 1 (2nd Version) of Zomedica Corp. (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the Commission on August 7, 2020 (File No. 001-38298))](http://www.sec.gov/Archives/edgar/data/1684144/000117184320005754/exh_31.htm) |

---

2<br>

**SIGNATURE**

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **ZOMEDICA CORP.** | **ZOMEDICA CORP.** |
| Date: August 20, 2025 | By: | */s/ Karen De-Haan Fullerton* |
|  | Name: | Karen De-Haan Fullerton |
|  | Title: | General Counsel and Corporate Secretary |

---

3<br>